- Report
- May 2024
- 187 Pages
Global
From €3224EUR$3,374USD£2,744GBP
€3583EUR$3,749USD£3,048GBP
- Report
- May 2024
- 182 Pages
Global
From €3224EUR$3,374USD£2,744GBP
€3583EUR$3,749USD£3,048GBP
- Report
- November 2023
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 150 Pages
Global
From €4635EUR$4,850USD£3,944GBP
- Report
- May 2024
- 193 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- March 2024
- 180 Pages
Global
From €5686EUR$5,950USD£4,838GBP
- Report
- February 2024
- 182 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- November 2023
- 181 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- February 2024
- 110 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- October 2023
- 190 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- July 2023
- 145 Pages
Global
From €3010EUR$3,150USD£2,561GBP
- Report
- February 2024
- 132 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- July 2023
- 155 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- August 2023
- 220 Pages
Global
€4582EUR$4,795USD£3,899GBP
- Report
- December 2023
- 300 Pages
Global
From €4582EUR$4,795USD£3,899GBP
- Report
- October 2023
- 300 Pages
Global
From €4582EUR$4,795USD£3,899GBP
- Report
- July 2023
- 223 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- October 2023
- 80 Pages
United States
From €2480EUR$2,595USD£2,110GBP
- Report
- October 2023
- 100 Pages
Africa
From €3627EUR$3,795USD£3,086GBP
- Report
- June 2020
- 115 Pages
Global
From €4539EUR$4,750USD£3,862GBP
The Thyroid Disorder market within the context of Endocrinology is a rapidly growing field of medicine. It focuses on the diagnosis and treatment of diseases related to the thyroid gland, such as hypothyroidism, hyperthyroidism, and thyroid cancer. Treatment options for these conditions include hormone replacement therapy, surgery, and radiation therapy. Endocrinologists also work to diagnose and treat other endocrine disorders, such as diabetes, obesity, and adrenal disorders.
The Thyroid Disorder market is driven by the increasing prevalence of thyroid disorders, as well as the development of new treatments and technologies. Endocrinologists are also increasingly focusing on preventive care, which is helping to reduce the burden of thyroid disorders.
Some companies in the Thyroid Disorder market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more